TheraRadar
← Back
Data updated: Mar 29, 2026

AM THERAP

CardiovascularInfectious DiseaseRespiratory
Generics

AM THERAP is a generic drug manufacturer focused on Cardiovascular, Infectious Disease, Respiratory.

1987
Since
19
Drugs
-
Trials
219
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

TRAZODONE HYDROCHLORIDE 2026-02-09
Labeling
TRAZODONE HYDROCHLORIDE 2026-02-09
Labeling
AMITRIPTYLINE HYDROCHLORIDE 2026-01-09
Labeling
LORAZEPAM 2026-01-05
Labeling
ACETAMINOPHEN AND CODEINE PHOSPHATE 2025-12-22
Labeling
ACETAMINOPHEN AND CODEINE PHOSPHATE 2025-12-22
Labeling
ACETAMINOPHEN AND CODEINE PHOSPHATE 2025-12-22
Labeling
ACETAMINOPHEN AND CODEINE PHOSPHATE 2025-12-22
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 46%
1 drugs
Infectious Disease 23%
0 drugs Phase 2: 1 Phase 1: 1
Respiratory 15%
0 drugs Phase 2: 1
Metabolic 8%
0 drugs Phase 1: 1
Oncology 8%
0 drugs Phase 1: 1

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Merck big-pharma
Oncology, Infectious Disease, Cardiovascular, Metabolic
Johnson & Johnson big-pharma
Oncology, Infectious Disease, Cardiovascular, Metabolic
Sanofi big-pharma
Metabolic, Oncology, Infectious Disease, Respiratory
AstraZeneca big-pharma
Oncology, Respiratory, Cardiovascular, Metabolic
Novartis big-pharma
Oncology, Cardiovascular, Respiratory